Cedenio, Baby Boy .
HRN: 23-86-59 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/10/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
10/10/2023
10/17/2023
IV
30mg
Q6hours
Sepsis
Waiting Final Action
Indication: Empiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes